Related Experiment Video
Updated: Apr 30, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Triple negative breast cancer
1Department of Radiobiology, Faculty of Science, Istanbul University, Istanbul, Turkey
Abstract:
Triple-negative breast cancers (TNBC), characterized by absence of the estrogen receptor (ER) and progesterone receptor (PR) and lack of overexpression of human epidermal growth factor receptor 2 (HER2), have a poor prognosis. To overcome therapy limitations of TNBC, various new approaches are needed. This mini-review focuses on discovery of new targets and drugs which might offer new hope for TNBC patients.
Insights
Triple-negative breast cancer (TNBC) lacks common treatment targets, leading to poor outcomes. New drug targets and therapies are crucial for improving treatment strategies and patient hope.
Area of Science:
- Oncology
- Medical Research
Background:
- Triple-negative breast cancer (TNBC) presents a significant clinical challenge due to the absence of estrogen receptors (ER), progesterone receptors (PR), and HER2 overexpression.
- Current therapeutic options for TNBC are limited, contributing to a generally poor prognosis for affected patients.
Purpose of the Study:
- This review explores novel therapeutic targets and drug discoveries for triple-negative breast cancer.
- The aim is to identify promising new avenues for treating TNBC and offer hope to patients.
Main Methods:
- Literature review of recent research on TNBC.
- Analysis of emerging drug candidates and molecular targets.
Main Results:
- Identification of several potential new targets for TNBC therapy.
- Discussion of promising preclinical and early-phase clinical data for novel drugs.
Conclusions:
- New therapeutic strategies targeting specific molecular pathways are essential for advancing TNBC treatment.
- Continued research into novel drug discovery holds promise for improving outcomes for triple-negative breast cancer patients.
More Related Videos
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
06:52Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence
Published on: November 5, 2021